Can individuals with low antibody responses to vaccines against other viruses acquire adequate SARS-CoV-2 antibody after vaccination with the BNT162b2 mRNA vaccine?
Wataru Ogura, View ORCID ProfileKouki Ohtsuka, Sachiko Matsuura, Takahiro Okuyama, Satsuki Matsushima, View ORCID ProfileSatoko Ymasaki, Hiroyuki Miyagi, Kumiko Sekiguchi, Hiroaki Ohnishi, Takashi Watanabe
doi: https://doi.org/10.1101/2021.12.26.21268358
Wataru Ogura
1Department of Clinical Laboratory, Kyorin University Hospital, Mitaka, Tokyo, Japan
Kouki Ohtsuka
2Department of Laboratory Medicine, Kyorin University School of Medicine, Mitaka, Tokyo, Japan
Sachiko Matsuura
1Department of Clinical Laboratory, Kyorin University Hospital, Mitaka, Tokyo, Japan
Takahiro Okuyama
1Department of Clinical Laboratory, Kyorin University Hospital, Mitaka, Tokyo, Japan
Satsuki Matsushima
2Department of Laboratory Medicine, Kyorin University School of Medicine, Mitaka, Tokyo, Japan
Satoko Ymasaki
2Department of Laboratory Medicine, Kyorin University School of Medicine, Mitaka, Tokyo, Japan
Hiroyuki Miyagi
1Department of Clinical Laboratory, Kyorin University Hospital, Mitaka, Tokyo, Japan
Kumiko Sekiguchi
1Department of Clinical Laboratory, Kyorin University Hospital, Mitaka, Tokyo, Japan
Hiroaki Ohnishi
2Department of Laboratory Medicine, Kyorin University School of Medicine, Mitaka, Tokyo, Japan
Takashi Watanabe
2Department of Laboratory Medicine, Kyorin University School of Medicine, Mitaka, Tokyo, Japan
Data Availability
All data produced in the present work are contained in the manuscript
Posted December 27, 2021.
Can individuals with low antibody responses to vaccines against other viruses acquire adequate SARS-CoV-2 antibody after vaccination with the BNT162b2 mRNA vaccine?
Wataru Ogura, Kouki Ohtsuka, Sachiko Matsuura, Takahiro Okuyama, Satsuki Matsushima, Satoko Ymasaki, Hiroyuki Miyagi, Kumiko Sekiguchi, Hiroaki Ohnishi, Takashi Watanabe
medRxiv 2021.12.26.21268358; doi: https://doi.org/10.1101/2021.12.26.21268358
Can individuals with low antibody responses to vaccines against other viruses acquire adequate SARS-CoV-2 antibody after vaccination with the BNT162b2 mRNA vaccine?
Wataru Ogura, Kouki Ohtsuka, Sachiko Matsuura, Takahiro Okuyama, Satsuki Matsushima, Satoko Ymasaki, Hiroyuki Miyagi, Kumiko Sekiguchi, Hiroaki Ohnishi, Takashi Watanabe
medRxiv 2021.12.26.21268358; doi: https://doi.org/10.1101/2021.12.26.21268358
Subject Area
Subject Areas
- Addiction Medicine (401)
- Allergy and Immunology (712)
- Anesthesia (204)
- Cardiovascular Medicine (2965)
- Dermatology (250)
- Emergency Medicine (444)
- Epidemiology (12781)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4609)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2939)
- Health Policy (1070)
- Hematology (391)
- HIV/AIDS (927)
- Medical Education (429)
- Medical Ethics (116)
- Nephrology (474)
- Neurology (4392)
- Nursing (237)
- Nutrition (646)
- Oncology (2284)
- Ophthalmology (650)
- Orthopedics (258)
- Otolaryngology (326)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (501)
- Public and Global Health (6980)
- Radiology and Imaging (1539)
- Respiratory Medicine (917)
- Rheumatology (443)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)